Skip to search formSkip to main contentSkip to account menu

Kaposi Sarcoma NCI Grade 2

Known as: Kaposi's Sarcoma NCI Grade 2, Kaposi's Sarcoma NCI Grade II 
National Institutes of Health

Related topics

Related topics

17 relations
Blood VesselBlood Vessel EndotheliumCardiovascular systemCommunicable Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
NCI-H460細胞のIN VITROでの薬物作用を,リアルタイム電気泳動によって検出した。【JST・京大機械翻訳】
2016
2016
Synthesis, characterization, and in vitro anti-tumor studies of bis imidazolium salts with alkyl chain linkers and naphthylmethyl substituents
Bis imidazolium salts, with alkyl chain linkers ranging from methylene to dodecyl, were synthesized with naphthylmethyl… 
2016
2016
Abstract 3103: The reduced immunogenicity anti-mesothelin immunotoxin RG7787 in combination with nab-paclitaxel has significant anti-tumor efficacy against primary mesothelioma cell lines and patient…
Mesothelin is a tumor differentiation antigen that is highly expressed in many cancers including malignant mesothelioma. RG7787… 
2014
2014
KT inhibition synergistically enhances growth-inhibitory effects f gefitinib and increases apoptosis in non-small cell lung cancer ell lines
Objectives: EGFR inhibitors are ineffective against most EGFR wild-type non-small cell lung cancer, for which novel treatment… 
2012
2012
Abstract LB-219: Neoadjuvant multidisciplinary phase II study (BRANCH) of an early bevacizumab schedule plus chemo-radiation therapy in rectal cancer: efficacy, safety, and biomarkers.
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL BACKGROUND: The benefits of combining bevacizumab…